TL;DR
- •Trintellix (vortioxetine) has a long half-life of ~66 hours — among the longest in modern antidepressants, second only to Prozac. This makes it structurally one of the easier antidepressants to discontinue.
- •Manufacturer materials have historically downplayed discontinuation risk, but real-world patient reports describe withdrawal symptoms in a meaningful minority — brain-zap-like sensations, dizziness, nausea, irritability, GI upset.
- •The standard tablet strengths (5mg, 10mg, 15mg, 20mg) allow reasonable linear-taper steps, but hyperbolic tapering may still be the better choice for long-term users.
- •Compared to SSRIs/SNRIs, Trintellix's 5-HT1A partial agonism and other multimodal mechanisms produce a different withdrawal profile — some patients find it gentler, others find it different but not necessarily easier.
- •Vortioxetine has gained prescribing momentum for patients sensitive to typical SSRI sexual dysfunction; tapering off may be motivated by cost (Trintellix has limited generic availability) rather than side effects.
- •For patients leaving Trintellix because they want a non-daily-medication treatment, ketamine offers an episodic-dosing alternative through a completely different mechanism.
Why people decide to taper
- •Original episode in long-term remission
- •Cost — Trintellix remains expensive with limited generic availability
- •GI side effects (nausea is the most common Trintellix complaint) that haven't resolved
- •Switching to a different antidepressant or mechanism
- •Plans to become pregnant (Trintellix has limited pregnancy data)
- •Emotional blunting or other side effects that persisted despite Trintellix's "kinder" reputation
What withdrawal looks like
Trintellix discontinuation is generally milder than SSRI/SNRI withdrawal because of the long half-life, but it's not absent. Symptoms typically appear 3-7 days after a dose reduction (later than SSRIs because the long half-life delays the kinetic drop). Reported symptoms include: dizziness, GI upset (nausea is the most-reported), headache, irritability, sleep changes, and occasional brain-zap-like sensations (less common than with SSRIs but still reported in patient communities). The "no discontinuation effects" claim some patients hear from prescribers reflects the favorable kinetics, not the absence of any withdrawal.
Typical taper timeline
Trintellix tapers are typically shorter than SSRI/SNRI tapers because of the favorable half-life. Short-term users (under 6 months) often complete in 2-4 weeks. Long-term users (3+ years) typically 4-8 weeks. The medication's own long half-life provides a built-in extended washout after the last dose — even abrupt stops produce a 1-2 week gradual decline.
Taper approaches
Options to bring to your prescriber. The dose-by-dose plan belongs to your prescriber, not this page.
Standard linear taper
Most patients tolerate standard step reductions every 1-2 weeks. The 5mg/10mg/15mg/20mg tablet strengths support reasonable taper steps without needing compounded formulations.
Hyperbolic taper for sensitive patients
For patients who experience withdrawal during a linear taper, smaller proportional reductions over a longer time produce fewer symptoms. The 5mg strength can be cut by some patients (discuss with prescriber — Trintellix tablets are not designated as scored, so this is off-label).
Slower taper for long-term users
Long-term users (3+ years) often benefit from extending the taper to 2-3 months, particularly if they experienced ANY withdrawal at earlier reductions. The long half-life forgives slower schedules.
Cross-taper to a different antidepressant
If switching to a different antidepressant class, cross-tapering (overlapping the two medications briefly) often works smoothly because Trintellix's long half-life smooths the transition kinetics.
Mechanism switch to ketamine
For patients leaving the antidepressant class entirely, ketamine's NMDA/glutamate mechanism provides a different pathway with no daily-medication dependence. The Trintellix taper itself is usually straightforward; ketamine becomes the new treatment model.
What’s specific to Trintellix (Vortioxetine)
Trintellix's ~66-hour half-life is the structural reason for its favorable discontinuation profile — second only to Prozac's combined fluoxetine-plus-norfluoxetine kinetics. Its multimodal mechanism (serotonin reuptake inhibition PLUS 5-HT1A partial agonism, 5-HT3 antagonism, 5-HT7 antagonism, 5-HT1D antagonism) produces a different pharmacology than typical SSRIs — which may explain why withdrawal symptoms, when they occur, sometimes feel different from SSRI discontinuation. The 5mg/10mg/15mg/20mg tablet strengths allow reasonable linear-taper steps. The 5mg is a meaningful endpoint for most patients, with the long half-life producing a self-tapering effect after the final dose. Trintellix has a more pronounced GI side effect profile during initiation than other modern antidepressants; nausea is the most-reported side effect and can also appear transiently during taper. Some patients find Trintellix's reputation for "easier discontinuation" gets oversold — manufacturer-funded studies show low withdrawal rates, but independent patient-community data describes a meaningful minority experiencing classic discontinuation symptoms.
Where ketamine fits
Trintellix patients leaving the medication often do so for reasons other than withdrawal difficulty (cost, GI effects, life-stage changes). The mechanism switch to ketamine offers a fundamentally different antidepressant pathway with episodic dosing rather than daily medication — many patients prefer this pattern once they've responded to ketamine. Starting ketamine alongside the Trintellix taper is clinically straightforward because Trintellix's long half-life and milder withdrawal mean the transition is rarely difficult. Many Tovani patients describe the Trintellix-to-ketamine transition as one of the cleaner antidepressant changes — without the multi-month tapering ordeal that defines SNRI discontinuation.
Check eligibility for ketamine therapy5-minute screening · Reviewed by a board-certified physician · FL & NJ
Frequently asked
Is Trintellix actually withdrawal-free?
No — but it's among the milder antidepressant tapers. The ~66-hour half-life produces a built-in self-taper after the last dose, which means most patients experience less severe withdrawal than with SSRIs or SNRIs. But "milder" is not "absent." Patient communities document real discontinuation experiences (dizziness, nausea, irritability) in a meaningful minority. The marketing language about "no discontinuation effects" reflects favorable kinetics, not the absence of any withdrawal.
How long does it take to taper off Trintellix?
Shorter than SSRI/SNRI tapers because of the long half-life. Short-term users: 2-4 weeks. Long-term users: 4-8 weeks for most, longer for sensitive patients. The 5mg/10mg/15mg/20mg tablet strengths allow reasonable step reductions. Discuss the specific schedule with your prescriber.
Why am I getting nausea when I reduce Trintellix?
GI upset (nausea, occasional GI cramping) is the most common Trintellix side effect during initiation AND can recur during taper. This isn't the classic "withdrawal" pattern of SSRIs — it's a kinetic response to the changing serotonin signaling. Usually transient (a few days) and resolves as the system adjusts.
Can I cut Trintellix tablets to reduce the dose?
Trintellix tablets aren't designated as scored, so cutting them is off-label and not officially recommended. Some patients do this with prescriber knowledge for fine dose adjustments; others use the 5mg strength as the lowest effective taper endpoint and rely on the long half-life for the final washout. Discuss with your prescriber.
Will ketamine work after long-term Trintellix?
Yes — Trintellix and ketamine work through different mechanisms (multimodal serotonin pharmacology vs NMDA antagonism) and are clinically compatible. Many patients start ketamine while on Trintellix and taper Trintellix after ketamine response is established. The Trintellix taper is typically straightforward enough that ketamine's role is more about offering an alternative long-term treatment model than managing difficult withdrawal.
Never taper without prescriber coordination
Withdrawal symptoms can mimic depression or anxiety relapse, and untreated relapse can be more dangerous than withdrawal. Stopping benzodiazepines abruptly can produce seizures. Bring this page to your prescriber as a conversation starter — they translate options into your specific plan.
References
- Kammerer M et al. 2026, Clinical Drug Investigation. Real-world study of vortioxetine in major depressive disorder — confirms favorable tolerability profile with low rates of treatment discontinuation due to side effects. PMID 41832924
- Horowitz MA et al. 2023, CNS Drugs. Hyperbolic tapering framework applies to all antidepressants including vortioxetine — proportional reductions produce less withdrawal than linear schedules. PMID 36513909
- Henssler J et al. 2024, Lancet Psychiatry. Meta-analysis of antidepressant discontinuation — discontinuation symptoms occur across all antidepressant classes including newer multimodal agents. PMID 38851198